Tag archive for ‘Shire plc’
Firazyr Has Excellent Potential in the Hereditary Angioedema Market (SHPGY, $96.48)
Investment Thesis This report is intended to highlight the potential for four current products and one in development for the treatment of hereditary angioedema (HAE), a rapidly growing market. The HAE market is in an early and dynamic period of growth that should last for the next several years. I project that the US market […]